Probing Liver Injuries Induced by Thioacetamide in Human In Vitro Pooled Hepatocyte Experiments
Open Access
- 13 March 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (6) , 3265
Abstract
Animal studies are typically utilized to understand the complex mechanisms associated with toxicant-induced hepatotoxicity. Among the alternative approaches to animal studies, in vitro pooled human hepatocytes have the potential to capture population variability. Here, we examined the effect of the hepatotoxicant thioacetamide on pooled human hepatocytes, divided into five lots, obtained from forty diverse donors. For 24 h, pooled human hepatocytes were exposed to vehicle, 1.33 mM (low dose), and 12 mM (high dose) thioacetamide, followed by RNA-seq analysis. We assessed gene expression variability using heat maps, correlation plots, and statistical variance. We used KEGG pathways and co-expression modules to identify underlying physiological processes/pathways. The co-expression module analysis showed that the majority of the lots exhibited activation for the bile duct proliferation module. Despite lot-to-lot variability, we identified a set of common differentially expressed genes across the lots with similarities in their response to amino acid, lipid, and carbohydrate metabolism. We also examined efflux transporters and found larger lot-to-lot variability in their expression patterns, indicating a potential for alteration in toxicant bioavailability within the cells, which could in turn affect the gene expression patterns between the lots. Overall, our analysis highlights the challenges in using pooled hepatocytes to understand mechanisms of toxicity.Keywords
Funding Information
- Medical Research and Materiel Command (W81XWH20C0031, CBCall14-CBS-05-2-0007, 5UL1 RR024975-03, P30 CA68485, P30 EY08126, G20 RR030956)
- Defense Threat Reduction Agency (W81XWH20C0031, CBCall14-CBS-05-2-0007, 5UL1 RR024975-03, P30 CA68485, P30 EY08126, G20 RR030956)
- Vanderbilt University Medical Center VANTAGE Core (W81XWH20C0031, CBCall14-CBS-05-2-0007, 5UL1 RR024975-03, P30 CA68485, P30 EY08126, G20 RR030956)
- Vanderbilt Ingram Cancer Center (W81XWH20C0031, CBCall14-CBS-05-2-0007, 5UL1 RR024975-03, P30 CA68485, P30 EY08126, G20 RR030956)
- Vanderbilt Vision Center (W81XWH20C0031, CBCall14-CBS-05-2-0007, 5UL1 RR024975-03, P30 CA68485, P30 EY08126, G20 RR030956)
- National Institutes of Health/National Center for Research Resources (W81XWH20C0031, CBCall14-CBS-05-2-0007, 5UL1 RR024975-03, P30 CA68485, P30 EY08126, G20 RR030956)
This publication has 81 references indexed in Scilit:
- Osteopontin Takes Center Stage in Chronic Liver DiseaseHepatology, 2020
- Inter‐individual and inter‐regional variations in enteric drug metabolizing enzyme activities: Results with cryopreserved human intestinal mucosal epithelia (CHIM) from the small intestines of 14 donorsPharmacology Research & Perspectives, 2020
- Thyroid Hormone Signaling and the LiverHepatology, 2020
- Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational SignificancesHepatology, 2018
- Genetics in liver diseases: From diagnostics to precise therapyClinical Liver Disease, 2017
- Systems toxicology of chemically induced liver and kidney injuries: histopathology‐associated gene co‐expression modulesJournal of Applied Toxicology, 2016
- The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver diseaseHepatology, 2014
- Canalicular ABC transporters and liver diseaseThe Journal of Pathology, 2011
- Ductular reactions in human liver: Diversity at the interfaceHepatology, 2011
- Retinoid metabolism during development of liver cirrhosisArchives of Biochemistry and Biophysics, 2005